Englander Institute for Precision Medicine
Found 855 results
Author Title Type [ Year(Desc)]
Filters: Clinical-trials-corner-issue-10(1) is   [Clear All Filters]
2025
Meleshko D, Yang R, Maharjan S, Danko DC, Korobeynikov A, Hajirasouliha I.  2025.  Blackbird: structural variant detection using synthetic and low-coverage long-reads.. Bioinform Adv. 5(1):vbaf151.
Powles T, Sridhar SS, Bellmunt J, Sternberg CN, Grivas P, Hunter E, Salter M, Powell R, Dring A, Green J et al..  2025.  Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.. Cancers (Basel). 17(14)
Moothedan E, Boyer M, Watts S, Abdel-Aty Y, Ghosh S, Rameau A, Sigaras A, Elemento O, Bensoussan Y.  2025.  The Bridge2AI-voice application: initial feasibility study of voice data acquisition through mobile health.. Front Digit Health. 7:1514971.
Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, Perez Dde Miguel, Venetis K, Dipasquale A, Ghazali N et al..  2025.  Cancer in a drop: Advances in liquid biopsy in 2024.. Crit Rev Oncol Hematol. 213:104776.
Martinelli C, Borea R, Shivahamy M, Dipasquale A, Saldanha EF, Ghazali N, Nicolo E, Stejskal P, Pontolillo L, Reduzzi C.  2025.  Cancer in a drop: Liquid biopsy highlights from the American Society of Clinical Oncology (ASCO) 2025 annual congress.. J Liq Biopsy. 9:100320.
Maheswaran S, Borea R, Perez Dde Miguel, Pisapia P, Ghazali N, Martinelli C, Stejskal P, Reduzzi C.  2025.  Cancer in a Drop: Liquid biopsy insights from AACR 2025.. J Liq Biopsy. 8:100304.
Longoria O, Rekowski J, Gupta S, Beije N, Pantel K, Efstathiou E, Sternberg C, Castellano D, Fizazi K, Tombal B et al..  2025.  Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancer.. JCI Insight.
Teng M, Guo J, Xu X, Ci X, Mo Y, Kohen Y, Ni Z, Chen S, Guo WYuan, Bakht M et al..  2025.  Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.. Cancer Cell.
Kadri S, Craven KE, Fussell AM, Gee EPS, Jordan D, Klee EW, Krumm N, Temple-Smolkin RL, Zehir A, Zhang W et al..  2025.  Clinical Bioinformatician Body of Knowledge-Bioinformatics and Software Core: A Report of the Association for Molecular Pathology.. J Mol Diagn.
Agarwal PK, Sternberg CN.  2025.  Clinical trials corner issue 11(1).. Bladder Cancer. 11(1):23523735241309418.
Nauseef JT, Chu TR, Hooper WF, Alonso A, Oku A, Geiger H, Goldstein ZR, Shah M, Sigouros M, Manohar J et al..  2025.  A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.. NPJ Precis Oncol. 9(1):91.
Müller-Dott S, Jaehnig EJ, Munchic KPham, Jiang W, Yaron-Barir TM, Savage SR, Garrido-Rodriguez M, Johnson JL, Lussana A, Petsalaki E et al..  2025.  Comprehensive evaluation of phosphoproteomic-based kinase activity inference.. Nat Commun. 16(1):4771.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..  2025.  Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 5(1):11.
Chew SMei, Teumer A, Matías-García PR, Gieger C, Winckelmann J, Suhre K, Herder C, Rathmann W, Peters A, Waldenberger M.  2025.  Cross-sectional and longitudinal association of seven DNAm-based predictors with metabolic syndrome and type 2 diabetes.. Clin Epigenetics. 17(1):58.
Jiang W, Jaehnig EJ, Liao Y, Shi Z, Yaron-Barir TM, Johnson JL, Cantley LC, Zhang B.  2025.  Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.. Nat Commun. 16(1):2766.
Kim YE, Dobko M, Li H, Shao T, Periyakoil P, Tipton C, Colasacco C, Serpedin A, Elemento O, Sabuncu M et al..  2025.  A Deep-Learning Model for Multi-class Audio Classification of Vocal Fold Pathologies in Office Stroboscopy.. Laryngoscope.
Wong EWP, Sahin M, Yang R, Lee UJ, Li D, Zhan YA, Misra R, Tomas F, Alomran N, Polyzos A et al..  2025.  Disruption of TAD hierarchy promotes LTR co-option in cancer.. Nat Genet.
Sternberg CN, Hussain M.  2025.  Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer? Transl Cancer Res. 14(5):2536-2538.
Nepali PR, Gonzalez-Kozlova E, Anegondi M, Dogra N, Archer M, Chakraborty G, Tewari AK, Hopkins BD, Kyprianou N.  2025.  Effect of TGF-β mediated phenotypic changes on prostate cancer cell anoikis response.. Oncogene.
Kocher T, Baumeister S-E, Völzke H, Nauck M, Meisel P, Suhre K, Völker U, Friedrich N, Holtfreter B.  2025.  Elevated Salivary Theobromine and Long-Term Improvement of Periodontal Health in Two Cohort Studies.. J Clin Periodontol.
Tian Y, Bhattacharya R, Yoo S, Jiang F, Park E, Granados GLara, Shen Y, Park K-S, Kaniskan HUmit, Jin J et al..  2025.  Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma.. iScience. 28(5):112387.
Cheng APellan, Widman AJ, Arora A, Rusinek I, Sossin A, Rajagopalan S, Midler N, Hooper WF, Murray RM, Halmos D et al..  2025.  Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling.. Nat Methods.
Sternberg CN, Squifflet P, Saad ED, Burdett S, Fisher D, Kurt M, Teitsson S, May JR, Patel MY, Stoeckle M et al..  2025.  Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.. Urol Oncol.
Sternberg CN, Squires P, Song Y, Wu A, Gao Y, Kataria RS, Li H.  2025.  Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-Analysis.. Oncol Ther.
Rizzo A, Mozgai S, Sigaras A, Rubin JE, Jotwani R.  2025.  Expert Consensus Best Practices for the Safe, Ethical, and Effective Design and Implementation of Artificially Intelligent Conversational Agent (i.e., Chatbot/Virtual Human) Systems in Health Care Applications.. J Med Ext Real. 2(1):209-222.